#93 - AMA with Jason Fried: Work-life balance, avoiding burnout, defining success, company culture, and more
The Peter Attia Drive
#118 - Lloyd Klickstein, M.D., Ph.D.: Rapamycin, mTOR inhibition, and the biology of aging
Lloyd Klickstein is the Chief Science Officer at resTORbio, a biopharmaceutical company that develops medications to target the biology of aging. In this episode, Lloyd discusses his company’s clinical application of rapamycin and its derivatives....
0:00
Key Smash Notes In This Episode
No segments available for this episode yet.